California Board of Pharmacy Agenda for Enforcement and Compounding Committee Meeting on September 10, 2013

NOTICE OF MEETING AND AGENDA

Enforcement and Compounding Committee Meeting

September 10, 2013

Contact Person:  Laura Hendricks
(916) 574-7918
Note:  This is a combined meeting to discuss enforcement and compounding matters.
An E-Pedigree meeting will occur on September 26, 2013, in El Segundo.
This committee meeting is open to the public and is accessible to the physically disabled.  A person who needs
a disability-related accommodation or modification in order to participate in the meeting may make a request
by contacting Laura Hendricks at (916) 574-7918, by emailing laura.hendricks@dca.ca.gov or sending a written
request to  Ms.  Hendricks  at the Board of Pharmacy, 1625 N. Market Blvd., Suite N-219, Sacramento, CA
95834.  Providing your request at least five business days before the meeting will help to ensure availability of
the requested accommodation.
Note:  Pharmacists and pharmacy technicians who attend the full committee meeting can be awarded two
hours of CE, in accordance with the board’s CE policy.  A maximum of four CE hours can be earned each year
by attending the meetings of two different board committees.
DATE:  September 10, 2013
PLACE:  Department of Consumer Affairs / Hearing Room
1625 N. Market Blvd
Sacramento, CA  95834
This meeting may be cancelled without notice.  For verification of the meeting, call (916) 574-7900 or access
the Board’s Web site at www.pharmacy.ca.gov.
Discussion and action may be taken on any item on the agenda.  The committee may discuss agenda items in
any order.  Board members who are not on the committee may attend, but may not vote.  Time limitations for
discussion and comment will be determined by the committee chair.
Agenda
Call to Order  9:30 a.m.
Page 1 of 2

Meeting Materials will be available on the board’s Web site at www.pharmacy.ca.gov by September 6, 2013
                                                                                                                          
I.  Enforcement Matters

a.
b.
c.
d.
Proposed Statutory Provisions to Prevent a Wholesaler From Purchasing Prescription Medication
From a Pharmacy When the Pharmacy Did Not Purchase the Medication From the Wholesaler
Review of Walgreens’ New Business Model for Pharmacies
Presentation From the California Product Stewardship Council on Take Back Programs for
Prescription Medications in California
Request from Da Vita Rx for Discussion Regarding Prescription Drugs Dispensed to Renal Clinics for
Administration to Patients
e.
f.
Review and Discussion of Federal Government Accountability Office Report on the Difficulties of
Regulating Internet Pharmacies
Role of a Pharmacist’s Corresponding Responsibility in the Dispensing of Controlled Substances
II.  Compounding Matters
a.
b.
c.
d.
Update on Pending California Legislation on Sterile Compounding: Senate Bill 294 (Emmerson) and
Assembly Bill 1045 (Quirk-Silva)
Update on Proposed Federal Legislation on Compounding
Subcommittee Recommendations to Amend California’s Compounding Regulations in 16 California
Code of Regulations Sections 1735 et seq. and 1751 et seq.
Recalls of Compounded Drugs Throughout the United States
III.  Future Meeting Dates
IV.  Closing Comments
V.  Public Comment on Items Not on the Agenda/Agenda Items For Future Meetings
Note: The committee may not discuss or take action on any matter raised during this public comment
section that is not included on this agenda, except to decide whether to place the matter on the agenda
of a future meeting. [Government Code Sections 11125, 11125.7(a)]
ADJOURN  4